Life Sciences Software Market Size, Share, and Growth Analysis

Life Sciences Software Market By Deployment (Cloud, On-Premise), By End User (Biotechnology and Pharmaceutical Companies, Medical Research Centers), By Application (Preclinical and Clinical Trials, Research and Development) By Region -Industry Forecast 2025-2032


Report ID: SQMIG45F2172 | Region: Global | Published Date: February, 2025
Pages: 195 |Tables: 64 |Figures: 68

Format - word format excel data power point presentation

Life Sciences Software Market Insights

Global Life Sciences Software Market size was valued at USD 14.70 Billion in 2023 and is poised to grow from USD 19.89 Billion in 2024 to USD 223.50 Billion by 2032, growing at a CAGR of 35.31% in the forecast period (2025-2032).

Life sciences software consist of a wide range of applications that are designed for supporting the operations, research, and regulatory compliance necessary for organizations in the pharmaceutical and biotechnology and medical device industries. Within this software category there are various solutions for laboratory information management systems (LIMS), clinical trial management systems (CTMS), electronic lab notebooks (ELN), patient registry databases, and others. The life science applications software market is booming due to the rise of digitization and automation needs in the life sciences sector. Factors like the focus on precision medicine, the expansion of biopharmaceutical research, and the rising demand for more effective regulatory compliance schemes, are also contributing to the growth.

With the trend toward reduced time-to-market for life science solutions and increased productivity of research and development, there is thus a growing need for integrated, scalable life science software solutions, which leads to market expansion. This life sciences software market growth is also driven by the trend in personalization and direction internationally to enhance healthcare delivery, with life sciences software serving as an essential part of the contemporary healthcare and biotech industry environment.

Market snapshot - (2025-2032)

Global Market Size

USD 14.70 Billion

Largest Segment

Cloud

Fastest Growth

On-Premise

Growth Rate

35.31% CAGR

Global Life Sciences Software Market ($ Bn)
Country Share for North America Region (%)

To get more reports on the above market click here to Buy The Report

Life Sciences Software Market Segments Analysis

The global life sciences software market is segmented into deployment, application, end user, and region. Based on deployment, the market is segmented into cloud and on-premises. Based on application, the market is segmented into preclinical and clinical trials, supply chain management, research and development, commercial engagement and branding, pharmacovigilance, and regulatory compliance. Based on end user, the market is segmented into biotechnology and pharmaceutical companies, medical research centers, medical device companies, and others. Based on region, the market is segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

Analysis by Deployment

Based on deployment, the cloud segment is dominating with the largest life sciences software market share. This growing market presence is because of the increasing need for scalable, highly flexible, and low-cost software products in the life sciences market. Cloud-based systems have a number of benefits over traditional on-premises systems such as lower IT infrastructure costs, improved data protection, and the flexibility to expand or contract as required by the organization. In addition, the cloud enables researchers and clinicians to work together in different geographic places effectively and in addition, it allows real-time data sharing and data analysis. This is particularly crucial in the life sciences field, where collaborative research and data analysis play a pivotal role in advancing medical research and drug development.

The on-premises segment is expected to witness significant growth during the forecast period. The on-premises solution segment in the life science software market is expanding rapidly due to a number of factors including concerns relating to data security, regulatory compliance and the desire for better control over sensitive data. Numerous life science organizations, especially ones subject to data privacy limitations or old systems want to retain their software applications on-premises. This is because they want to guarantee they have control over the data and compliance with the rules and regulations. Additionally, on-premises solutions provide customization and integration adaptability that is needed to meet the specific needs of organizations and workflows.

Analysis by End User

Based on end user, the biotechnology and pharmaceutical company segment is dominating the life sciences software market. The biotechnology and pharmaceutical companies are leading in the market because they are the biggest end-users both in terms of revenue generation and consumption volume. Life science software is utilized for increasing speed of the process of discovery and development of the drugs, to optimize the efficacy of clinical trials, to focus on a specific population of the patients, to see the effect of the drug, to analyze the patient behavioral activities over healthcare outcome, and to further manage the patient's safety and risk management.

As per the life sciences software market analysis, the medical research centers segment is expected to be the fastest growing segment. The medical centers segment is growing rapidly because they use these solutions for academic research, data analysis, and scientific collaboration. A growing number of clinical or contract research organizations are using life sciences software to offer derivative services to the pharmaceutical and biotech industries and thus enable efficient processes of drug development and clinical trial management. Life sciences software plays an indispensable role in patient data management, precision medicine, and customized treatment planning by health care professionals. Life sciences software has been instrumental in accelerating vaccine development, conducting remote clinical research and providing real-time monitoring of drug treatment efficacy and safety.

Global Life Sciences Software Market Analysis by Deployment

To get detailed analysis on other segments, Request For Free Sample Report

Life Sciences Software Market Regional Insights

North America is dominating with the largest life sciences software market share. This region is leading in the market due to a robust pharmaceutical and biotech base as well as to a growing commitment to bringing research and development to fruition. North America, and in particular the USA, is housing many of the world's best life sciences companies and research organizations. These centers are leading the way in selecting and using the most sophisticated software applications to benefit drug development, clinical trials, and patient care. In addition, the region also has a regulatory framework, spearheaded by the FDA, that is leading to the introduction of digital innovations in order to achieve both compliance and effectiveness in healthcare and life sciences business processes. Also, due to the existence of the advanced healthcare IT system as well as the increase digital literacy of the experts, it seems to facilitate the implementation of the sophisticated software solutions, thus, expanding the market.

Asia Pacific is anticipated to witness the fastest growth during the life sciences software market forecast period.  The market in the Asia Pacific region is growing rapidly because of rapid growth in the economy, which is leading to increased investments in healthcare infrastructure and research and development activities. Moreover, there is also a growing demand for advanced healthcare solutions and technologies. This is due to several reasons, for example, increase in healthcare costs, aging population and the growing frequency of chronic conditions. In addition, the government activities are also encouraging innovative technologies and technology adoption to keep pace with the regional life science software market expansion.

Global Life Sciences Software Market By Geography
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Life Sciences Software Market Dynamics

Drivers

Increasing Speed of Drug Development

  • The growing pressure to accelerate drug development pipelines is one of the major forces behind the growth of life sciences software market. With the emergence of increasingly challenging global health issues, such as pandemics and chronic disease, pharmaceutical companies and research organisations are facing growing pressure to speed up the identification, development and provision of new therapeutics. Life sciences software helps in increasing speed by enabling more efficient data management, analysis, and collaboration across the drug development lifecycle.

Increasing Use of Advanced Software

  • The advanced software solutions help in streamlining workflows for clinical trials, regulatory compliance, and personalized medicine. It also contributes to a reduction of substantial time and cost that occur with making new drugs available to the market. This increasing requirement for efficiency in drug development not only meets urgent healthcare needs but also provides competitive advantages for companies in the life sciences sector, fueling the demand for advanced software solutions.

Restraints

High Expense of Implementation

  • The fact that life sciences software solutions come with high costs is one major market restraint. These costs are not incurred only with the purchase and/or subscription fees, but also with the costs of integration, customization, training and continuous support. For small to medium sized enterprises (SMEs) and academic institutions, these financial demands can be too restrictive to enable adoption and implement the advanced software tools.

Rising Concern about Data Security

  • Life sciences industry works with highly confidential data, such as patient data, confidential research data, and regulatory applications. The difficulty is in adapting effective security measures to rapidly emerging threats and regulatory requirements without compromising access and performance of the software. Lack of proper consideration of this challenge can lead to heavy financial penalties, reputation loss, and patient harm, highlighting the urgent requirement for secure and compliant software in the life science industry.

Request Free Customization of this report to help us to meet your business objectives.

Life Sciences Software Market Competitive Landscape

Key players in life sciences software market are heavily investing in research and development to develop breakthrough solutions that solve the changing demands of the market. Major vendors in the life sciences software market are now actively engaged in developing software that can interoperate with other software components, like electronic health records (EHRs) and laboratory information management systems (LIMS), to enhance data sharing as well as process automation. Furthermore, companies are buying into cloud-based products for more responsiveness and capacity. The life sciences software industry is also undergoing an AI/ML technology adoption trend in order to enhance data analysis and decision making. This is predicted to fuel life sciences software market growth during the forecast.

Top Player’s Company Profile

  • Thermo Fisher Scientific Inc.
  • IQVIA
  • SAP SE
  • IBM Corporation
  • Oracle Corporation
  • Medidata Solutions
  • PerkinElmer, Inc.
  • Veeva Systems Inc.
  • LabWare, Inc.
  • ArisGlobal
  • Accenture plc
  • SAS Institute
  • Other Key Players

Recent Developments

  • In February 2024, ArisGlobal and Nextrove announced a new partnership. The partnership opens up a greater pool of high-quality resources that are accessible to pharmaceutical enterprises so they can implement modernized LifeSphere solutions.
  • In February 2024, Oracle Life Sciences and ObvioHealth expanded their partnership worldwide with effective efforts toward introducing trials in the Asia Pacific. The partnership would enable the effective capture, incorporation, and analysis of various sources of clinical trial health information from clinicians, participants, labs, and devices across the globe.
  • In October 2023, Trinity introduced Launch Accelerator 2.0 to offer smart, skilled launch planning with personalization and tech-driven support for pharma users. Launch Accelerator 2.0 is a flexible cloud-driven project management tool that uses real-world launches to monitor cross-functional Project Management Office (PMO) teams and Global Launch.

Life Sciences Software Key Market Trends

Life Sciences Software Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.

As per SkyQuest analysis, life science software is of great importance to the development of research development in the life sciences industry. This software is used for data management related to patients, data analysis in the realm of pharmaceuticals, and life sciences laboratories. Pharma companies and research institutes in this area make use of these tools for workflow optimization, inventory control and supply chain optimization. The introduction of AI models, including generative AI and VAEs, to life science software has dramatically changed the industry. These models are used for finding drug-like molecules, finding target proteins, and for creating synthetic gene orders synthetic biology. Data analytics is an essential element of life science software, leading to scientific discovery by analyses of genome sequence repositories and integrated data.

Report Metric Details
Market size value in 2023 USD 14.70 Billion
Market size value in 2032 USD 223.50 Billion
Growth Rate 35.31%
Base year 2024
Forecast period (2025-2032)
Forecast Unit (Value) USD Billion
Segments covered
  • Deployment
    • Cloud and On-Premises
  • Application
    • Preclinical and Clinical Trials, Supply Chain Management, Research and Development, Commercial Engagement and Branding, Pharmacovigilance, and Regulatory Compliance
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • Thermo Fisher Scientific Inc.
  • IQVIA
  • SAP SE
  • IBM Corporation
  • Oracle Corporation
  • Medidata Solutions
  • PerkinElmer, Inc.
  • Veeva Systems Inc.
  • LabWare, Inc.
  • ArisGlobal
  • Accenture plc
  • SAS Institute
  • Other Key Players
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Life Sciences Software Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Life Sciences Software Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Life Sciences Software Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Life Sciences Software Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Life Sciences Software Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Life Sciences Software Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW

REQUEST FOR SAMPLE

Want to customize this report? REQUEST FREE CUSTOMIZATION

FAQs

Global Life Sciences Software Market size was valued at USD 14.70 Billion in 2023 and is poised to grow from USD 19.89 Billion in 2024 to USD 223.50 Billion by 2032, growing at a CAGR of 35.31% in the forecast period (2025-2032).

Key players in life sciences software market are heavily investing in research and development to develop breakthrough solutions that solve the changing demands of the market. Major vendors in the life sciences software market are now actively engaged in developing software that can interoperate with other software components, like electronic health records (EHRs) and laboratory information management systems (LIMS), to enhance data sharing as well as process automation. Furthermore, companies are buying into cloud-based products for more responsiveness and capacity. The life sciences software industry is also undergoing an AI/ML technology adoption trend in order to enhance data analysis and decision making. This is predicted to fuel life sciences software market growth during the forecast. 'Thermo Fisher Scientific Inc.', 'IQVIA', 'SAP SE', 'IBM Corporation', 'Oracle Corporation', 'Medidata Solutions', 'PerkinElmer, Inc.', 'Veeva Systems Inc.', 'LabWare, Inc.', 'ArisGlobal', 'Accenture plc', 'SAS Institute', 'Other Key Players'

The growing pressure to accelerate drug development pipelines is one of the major forces behind the growth of life sciences software market. With the emergence of increasingly challenging global health issues, such as pandemics and chronic disease, pharmaceutical companies and research organisations are facing growing pressure to speed up the identification, development and provision of new therapeutics. Life sciences software helps in increasing speed by enabling more efficient data management, analysis, and collaboration across the drug development lifecycle.

Incorporation of Artificial Intelligence and Machine Learning: The integration of AI and ML technologies presents a substantial opportunity in the life sciences software market. These technologies can change different stages of life sciences, ranging from the development and trial of drugs to the patient diagnostic and medicine of patients, and so on. Due to the capabilities of AI and ML, large datasets can be analyzed faster and better than conventional approaches, revealing insights and patterns that can open new horizons in research and treatment strategies.

North America is dominating with the largest life sciences software market share. This region is leading in the market due to a robust pharmaceutical and biotech base as well as to a growing commitment to bringing research and development to fruition. North America, and in particular the USA, is housing many of the world's best life sciences companies and research organizations. These centers are leading the way in selecting and using the most sophisticated software applications to benefit drug development, clinical trials, and patient care. In addition, the region also has a regulatory framework, spearheaded by the FDA, that is leading to the introduction of digital innovations in order to achieve both compliance and effectiveness in healthcare and life sciences business processes. Also, due to the existence of the advanced healthcare IT system as well as the increase digital literacy of the experts, it seems to facilitate the implementation of the sophisticated software solutions, thus, expanding the market.

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Life Sciences Software Market

Report ID: SQMIG45F2172

[email protected]
USA +1 351-333-4748

BUY NOW GET FREE SAMPLE